AARP Responds to First 10 Medicare Part D Drugs Selected for Historic Negotiation
AARP Responds to First 10 Medicare Part D Drugs Selected for Historic Negotiation WASHINGTON— AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ list of the first 10 drugs to be negotiated for lower prices by Medicare: “AARP […]